Jpmorgan Chase & Co - May 30, 2025 SCHEDULE 13G/A Report for REGENERON PHARMACEUTICALS, INC. Common Stock - par value $.001 per share (REGN)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: REGENERON PHARMACEUTICALS, INC. Common Stock - par value $.001 per share
Symbol: REGN
Shares outstanding: 108M shares
Disclosed Ownership: 4.74M shares
Ownership: 4.4%
Form type: SCHEDULE 13G/A
Date filed: 6/5/2025, 11:11 AM
Date of event: May 30, 2025
Previous filing: Apr 22, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	4.4%	4.74M	4.19M	41.5K	Rachel Tsvaygoft	Vice President